[go: up one dir, main page]

ES390603A1 - Vaccine - Google Patents

Vaccine

Info

Publication number
ES390603A1
ES390603A1 ES390603A ES390603A ES390603A1 ES 390603 A1 ES390603 A1 ES 390603A1 ES 390603 A ES390603 A ES 390603A ES 390603 A ES390603 A ES 390603A ES 390603 A1 ES390603 A1 ES 390603A1
Authority
ES
Spain
Prior art keywords
virus
procedure
virulent
vaccine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES390603A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES390603A1 publication Critical patent/ES390603A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A procedure for the preparation of a live varicella virus useful as an antigen in a vaccine, which can evoke in man an antibody response against a virulent varicella virus without producing the serious clinical manifestations of the disease, the procedure of which is to pass serially virulent virus at 30-34ºC in a tissue culture preparation selected from the group consisting of varieties of human diploid cells and primary cells of ape origin, a number of times sufficient to attenuate the virus. (Machine-translation by Google Translate, not legally binding)
ES390603A 1970-04-28 1971-04-26 Vaccine Expired ES390603A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3276970A 1970-04-28 1970-04-28

Publications (1)

Publication Number Publication Date
ES390603A1 true ES390603A1 (en) 1974-04-01

Family

ID=21866708

Family Applications (1)

Application Number Title Priority Date Filing Date
ES390603A Expired ES390603A1 (en) 1970-04-28 1971-04-26 Vaccine

Country Status (11)

Country Link
AT (1) AT303965B (en)
AU (1) AU2788871A (en)
BE (1) BE766333A (en)
DE (1) DE2120426A1 (en)
ES (1) ES390603A1 (en)
FR (1) FR2092100B1 (en)
GB (1) GB1293310A (en)
HU (1) HU163131B (en)
IL (1) IL36649A0 (en)
NL (1) NL7103524A (en)
ZA (1) ZA712711B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077590A (en) * 1980-01-25 1981-12-23 Wistar Inst Highly attenuated varicella virus vaccine and production thereof
FR2952825B1 (en) 2009-11-24 2012-05-25 Goaster Jacqueline Le USE OF A VZV / HSV3 VIRUS VACCINE FOR TREATING HERPETIC INFECTIONS WITH HSV1 VIRUS AND / OR HSV2 VIRUS

Also Published As

Publication number Publication date
FR2092100A1 (en) 1972-01-21
NL7103524A (en) 1971-11-01
DE2120426A1 (en) 1971-11-11
IL36649A0 (en) 1971-06-23
AT303965B (en) 1972-12-27
BE766333A (en) 1971-10-27
GB1293310A (en) 1972-10-18
ZA712711B (en) 1972-12-27
FR2092100B1 (en) 1974-08-30
HU163131B (en) 1973-06-28
AU2788871A (en) 1972-10-26

Similar Documents

Publication Publication Date Title
Theiler et al. The use of yellow fever virus modified by in vitro cultivation for human immunization
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
GB1457382A (en) Process for preparing live varticella vaccines
Huebner et al. Rickettsialpox: A newly recognized rickettsial disease: V. Recovery of Rickettsia akari from a house mouse (Mus musculus)
IT7822203A0 (en) VACCINE CONSISTING OF LIVING VIRUS FOR VACCINATION AGAINST POULTRY PSEUDOPLEST AND SIMILAR AND METHOD FOR ITS PREPARATION.
SE7504221L (en) CELL VIRUS VACCINE AND METHODS FOR MANUFACTURING THE VACCINE.
GB1292803A (en) Improvements relating to the production of antigens
SE7512828L (en) CALICIVIRUSVACCIN
ES458113A1 (en) Equine rhinopneumonitis virus
Skinner et al. Use of unweaned white mice in foot-and-mouth disease research
ES390603A1 (en) Vaccine
DK133311C (en) PROCEDURE FOR THE PREPARATION OF A VACCINE TO COMBAT MAREK'S DISEASE CONTAINING LIVING NON-WEAK, CELL-ASSOCIATED VIRUS
Hazrati et al. Serological studies of African horse-sickness virus with emphasis on neutralization test in tissue culture
GB1071922A (en) Improvements in or relating to vaccines
IT1148013B (en) PROCEDURE FOR OBTAINING TOXOPLASM PREPARATIONS FOR THE DIAGNOSIS OF TOXOPLASMOSIS AND PREPARATIONS SO OBTAINED
ES419996A1 (en) A PROCEDURE FOR ATTENUATING A TERNE-ROS DIARRHEA VIRUS.
ES437787A1 (en) A procedure for the preparation of a live virus atenuado de varicela. (Machine-translation by Google Translate, not legally binding)
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
ES330274A1 (en) Procedure to prepare a vaccine against mumps. (Machine-translation by Google Translate, not legally binding)
Sooter et al. Encephalitis in Midwest IV. Western Equine Encephalomyelitis Virus Recovered from Nestling Wild Birds in Nature
Schieble et al. Rhinoviruses: an antigenic study of the prototype virus strains
GB1481650A (en) Chemical processes and products
World Health Organization Draft agenda: Expert Committee on Smallpox, Geneva, 14-20 January 1964
ES471766A1 (en) A PROCEDURE FOR PREPARING A LIVING VIRUS ATTENUATED DELA PARA-INFLUENZA